Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma (Q47606657)

4 February 2018

title

Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma (English)

1 reference

4 February 2018

author

Michael Boe Møller

series ordinal

1

1 reference

4 February 2018

author name string

Niels T Pedersen

series ordinal

2

1 reference

4 February 2018

Bjarne E Christensen

series ordinal

3

1 reference

4 February 2018

publication date

1 October 2003

1 reference

4 February 2018

American Journal of Hematology

published in

1 reference

4 February 2018

volume

74

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

page(s)

94-98

1 reference

4 February 2018

Advanced diffuse histiocytic lymphoma, a potentially curable disease

cites work

1 reference

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

Non-Hodgkin's lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry. The Danish LYEO-Study Group

21 January 2018

1 reference

Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO.

21 January 2018

1 reference

Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group

21 January 2018

1 reference

Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

Second cancers among long-term survivors of non-Hodgkin's lymphoma

21 January 2018

1 reference

Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.

21 January 2018

1 reference

Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.

21 January 2018

1 reference

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

21 January 2018

1 reference

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

Prognostic variables in patients with diffuse large-cell lymphoma treated with MACOP-B

21 January 2018

1 reference

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience

21 January 2018

1 reference

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs

21 January 2018

1 reference

Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins

21 January 2018

1 reference

Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.10391

1 reference

4 February 2018

1 reference

4 February 2018